Following the UK’s triggering of Article 50 to leave the European Union, the HPRA, together with medicines agencies in Europe, is making preparations to ensure that we continue to deliver on our patient and animal health remit even if the UK fully exits the current systems on 29 March 2019. There are potential implications for the European network as a whole and particularly for Ireland with its shared marketplace.
Aim of the event
Agenda for Brexit Stakeholder event 1 Feb 2019
The HPRA wishes to engage with industry stakeholders to outline the activities which the organisation is undertaking, to hear from them in respect of their ongoing preparatory actions and to discuss any regulatory matters and topics of mutual concern.
The meeting will focus on medicines for human and veterinary use as well as medical devices and will include short presentations from speakers, followed by an open forum to allow questions, identify areas of concerns and share information.
Speakers will include representatives from the human and veterinary medicines, and medical devices sectors.
Who should attend?
This event is open to industry professionals across manufacturers, distributors, and marketing authorisation holders operating in Ireland or the UK and those companies who may wish to develop a presence in Ireland.
Please note as there are limited places available, priority will be given to regulatory professionals within industry.
Date, venue and fees
Date: 1 February 2019
Venue: Crowne Plaza Hotel, Santry
Time: 10.30 – 1.30 pm, registration from 9.30am
Refreshments will be available from 9.30am.
There is no fee for this event
This event is now at capacity and registration is now closed.
If you have any queries please email email@example.com
Download our Brexit guidance document or visit our dedicated Brexit webpage for more information - www.hpra.ie/brexit